HIV/AIDS Clinical Trials

Find HIV/AIDS Clinical Trials Near You

Psychophysiological Biomarkers to Assess the Effectiveness of Surface EMG Biofeedback as an Alternative Therapy to Reduce Chronic Low Back Pain

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The prevalence of chronic low back pain (CLBP) among the Pakistani population is reported to be as high as 78% leading towards different physiological and psychosocial alterations with the worst cases suffering from disabilities. CLBP is a multifactorial phenomenon in which age, gender, comorbidities, lifestyle conditions, profession, working hours, and different stressors play their roles in its causation. However, different therapeutic techniques have been determined to reduce CLBP. Thus, this study aimed to assess the effectiveness of the biofeedback surface EMG (sEMG) technique in reducing chronic low back pain among sufferers in the long run.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 25
Maximum Age: 75
Healthy Volunteers: f
View:

• Individuals who constantly experience low back pain for the last three months.

• Individuals who seek care from healthcare provider due to low back pain

• Individuals with average pain intensity, were assessed using the Brief Pain Inventory (BPI) over the past week ≥ 2 on a 0-10 scale.

• Individuals with an average Oswestry Disability Index (ODI) score ≥ 4.

• Individuals with State-Trait Anxiety Inventory (STAI) score ≥ 20.

Locations
Other Locations
Pakistan
Psychophysiology Lab, University of Karachi
RECRUITING
Karachi
Contact Information
Primary
Amaila Fazal
amaila.fazal@gmail.com
+923102686516
Time Frame
Start Date: 2024-03-01
Estimated Completion Date: 2026-01
Participants
Target number of participants: 200
Treatments
Experimental: sEMG Biofeedback Intervention
Participants in the intervention group will receive biofeedback surface EMG (sEMG) therapy as an alternative therapy to reduce chronic low back pain
No_intervention: Control
Participants in the control group will receive usual care
Related Therapeutic Areas
Sponsors
Collaborators: University of Karachi
Leads: Amaila Fazal [afazal]

This content was sourced from clinicaltrials.gov